【结 构 式】 |
【分子编号】13879 【品名】methyl 4-[[(1S)-1-benzyl-2-bromoethyl]oxy]benzoate 【CA登记号】 |
【 分 子 式 】C17H17BrO3 【 分 子 量 】349.22418 【元素组成】C 58.47% H 4.91% Br 22.88% O 13.74% |
合成路线1
该中间体在本合成路线中的序号:(II)CP-72467-2 has been prepared by two synthetic routes which share a common intermediate. 1) In the initial route, diazotization of D-phenylalanine followed by esterification afforded the methyl ester of (R)-phenyllactic acid (I). Mitsunobu coupling with methyl 4-hydroxybenzoate using diisopropyl azodicarboxylate, selective reduction with sodium borohydride, and conversion to the bromide by in situ generation of triphenylphosphine dibromide produced intermediate (II). Friedel-Crafts alkylation of (II) using alpha-hydroxyhippuric acid/methanesulfonic acid, azalactone formation with acetic anhydride/triethylamine, followed by in situ spiroalkylation produced the N-benzoyl amino acid (III). Oxidative decarboxylation of (III) with 15% sodium hypochlorite led to the chromanone (V), presumably through hydrolysis of the intermediate N-benzoyl imine (IV). Catalytic hydrogenation over 10% Pd on carbon of the chromanone (V), reduction of the ester with Red-Al, and subsequent oxidation of the alcohol with manganese dioxide afforded the key aldehyde intermediate (VI). Condensation of aldehyde (VI) with 2,4-thiazolidinedione/pyridine, catalytic hydrogenation of the resultant olefin, and salt formation with sodium methoxide produced CP-72467-2. 2) An alternative synthesis of the key intermediate aldehyde (VI) utilizes an enzymatic resolution of the benzopyran ester (VII). Reduction of the 2(R)-ester with sodium borohydride followed by reaction with triflic anhydride generates the triflate (VIII). Copper-catalyzed reaction of the triflate (VIII) with phenyl magnesium bromide afforded the benzyl derivative (IX), which is readily formylated with phosphorous oxychloride/N-methyl formanilide to produce aldehyde (VI).
【1】 Clark, D.A.; Goldstein, S.W.; Volkmann, R.A.; et al.; Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents. J Med Chem 1991, 34, 1, 319. |
【2】 Stevenson, R.W.; Urban, F.J.; Clark, D.A.; Englitazone Sodium. Drugs Fut 1992, 17, 3, 182. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
11703 | D-Phenylalanine; (R)-Phenylalanine | 673-06-3 | C9H11NO2 | 详情 | 详情 | |
((VII)-R) | 13885 | ethyl (2R)-3,4-dihydro-2H-chromene-2-carboxylate | C12H14O3 | 详情 | 详情 | |
(I) | 13878 | methyl (2R)-2-hydroxy-3-phenylpropanoate | C10H12O3 | 详情 | 详情 | |
(II) | 13879 | methyl 4-[[(1S)-1-benzyl-2-bromoethyl]oxy]benzoate | C17H17BrO3 | 详情 | 详情 | |
(III) | 13880 | (2S)-4-(Benzoylamino)-2-benzyl-6-(methoxycarbonyl)-3,4-dihydro-2H-chromene-4-carboxylic acid | C26H23NO6 | 详情 | 详情 | |
(IV) | 13881 | methyl (2S)-4-(acetylimino)-2-benzyl-2,3-dihydro-4H-chromene-6-carboxylate | C20H19NO4 | 详情 | 详情 | |
(V) | 13882 | methyl (2S)-2-benzyl-4-oxo-3,4-dihydro-2H-chromene-6-carboxylate | C18H16O4 | 详情 | 详情 | |
(VI) | 13883 | (2R)-2-Benzyl-3,4-dihydro-2H-chromene-6-carbaldehyde | C17H16O2 | 详情 | 详情 | |
(VII) | 13884 | ethyl 2-chromanecarboxylate | C12H14O3 | 详情 | 详情 | |
(VIII) | 13886 | (2R)-3,4-dihydro-2H-chromen-2-ylmethyl trifluoromethanesulfonate | C11H11F3O4S | 详情 | 详情 |